证券记录 · 已归档季度
PODD
Insulet Corp. · Healthcare · Medical - Devices
21被追踪持有人
-2Δ持有人
34.19M持有股份
$10.74B报告持仓市值
+0新建仓位
−2清仓
动量输入（同类管理人）：
持有人广度 -8.7% ·
股份流向 +1.7% ·
净新建仓位 -9.5%
· 公式
集中增持：持股数量上升，持有人数量减少
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q2 2025
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q3 2026 | 2 | -1 | 427.34K | $55.53M | n/a | −1 |
| Q2 2026 | 160 | 0 | 53.39M | $8.14B | +7 | −6 |
| Q1 2026 | 162 | -3 | 53.76M | $11.28B | +2 | −6 |
| Q4 2025 | 164 | +1 | 61.46M | $17.44B | +2 | n/a |
| Q3 2025 | 24 | +1 | 35.22M | $10.87B | +1 | −1 |
| Q2 2025 | 21 | -2 | 34.19M | $10.74B | n/a | −2 |
| Q1 2025 | 20 | +1 | 10.99M | $2.88B | +1 | n/a |
| Q4 2024 | 19 | 0 | 11.49M | $3.00B | +1 | −1 |
| Q3 2024 | 18 | 0 | 8.60M | $2.00B | +1 | −1 |
| Q2 2024 | 18 | n/a | 10.07M | $2.03B | n/a | n/a |
持有人 · Q2 2025
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | The Vanguard Group ✦ (被动) | 8.71M | n/a | $2.74B | 0.0% | n/c | 1 | SEC ↗ ×5 |
| 2 | Fidelity (FMR) ✦ | 7.51M | n/a | $2.36B | 0.1% | n/c | 1 | SEC ↗ ×7 |
| 3 | BlackRock ✦ (被动) | 6.41M | n/a | $2.02B | 0.0% | n/c | 1 | SEC ↗ ×23 |
| 4 | State Street Global Advisors ✦ (被动) | 3.06M | +1.1% | $960.21M | 0.0% | ▲ Add | 3 | SEC ↗ ×2 |
| 5 | Baillie Gifford ✦ | 2.14M | -5.1% | $670.80M | 0.5% | ▼ Trim | 5 | SEC ↗ ×4 |
| 6 | Geode Capital Management ✦ (被动) | 1.93M | +3.1% | $603.21M | 0.0% | ▲ Add | 5 | SEC ↗ ×2 |
| 7 | Norges Bank ✦ (被动) | 1.03M | +2.1% | $324.69M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 8 | Citadel Advisors ✦ | 771.55K | +436.0% | $242.40M | 0.2% | ▲ Add | 5 | SEC ↗ ×2 |
| 9 | Marshall Wace ✦ | 628.57K | +4.0% | $197.48M | 0.2% | ▲ Add | 5 | SEC ↗ ×2 |
| 10 | Renaissance Technologies ✦ | 374.26K | +135.1% | $117.58M | 0.2% | ▲ Add | 4 | SEC ↗ |
| 11 | Two Sigma Investments ✦ | 363.43K | +2105.2% | $114.18M | 0.2% | ▲ Add | 5 | SEC ↗ |
| 12 | Wellington Management ✦ | 282.97K | -18.2% | $88.90M | 0.0% | ▼ Trim | 5 | SEC ↗ ×4 |
| 13 | Millennium Management ✦ | 234.63K | -13.0% | $73.72M | 0.1% | ▼ Trim | 5 | SEC ↗ |
| 14 | T. Rowe Price ✦ | 224.06K | +8.6% | $70.39M | 0.0% | ▲ Add | 5 | SEC ↗ ×3 |
| 15 | PRIMECAP Management ✦ | 188.72K | -55.6% | $59.29M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 16 | Capital World Investors ✦ | 168.00K | 0.0% | $52.78M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 17 | AQR Capital Management ✦ | 107.57K | +28.6% | $33.70M | 0.0% | ▲ Add | 5 | SEC ↗ ×5 |
| 18 | Fisher Asset Management ✦ | 33.52K | -27.8% | $10.53M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 19 | Arrowstreet Capital ✦ | 26.77K | -66.5% | $8.41M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 20 | Gotham Asset Management ✦ | 5.29K | -41.8% | $1.66M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 21 | Bridgewater Associates ✦ | 2.30K | -25.8% | $722,928 | 0.0% | ▼ Trim | 5 | SEC ↗ |
"持仓权重"指该仓位占该管理人13F申报股票组合市值的比例，即持仓信心指标。✦ = 精选管理人。
新增买入方
| 本季度无新增被追踪买入方。 |
已清仓
| Adage Capital Partners | $65.03M | 曾为 0.1% |
| Point72 Asset Management | $5.98M | 曾为 0.0% |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 779 持有人, 69.27M 股份, $13.82B 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
持有该证券的受追踪机构最常同时持有的其他证券：基于共同持有计数，而非基本面关联。
公开市场买入 (P)
Aug 21
McEvoy Ashley
Officer, Director · President and CEO · 1.10K 股 @ 147.47 · $162,217
公开市场卖出 (S)
在我们的覆盖窗口内无内部人士公开市场卖出记录。
授予、行权及税务代扣代缴在本平台均不计入买入或卖出。 方法论
Aug 06
SC 13G/A: FMR LLC
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q2 2025 ·
方法论 ·
通过API获取此数据